aluates Reports

$ 0.0

Automative

Global 1,4-Alpha-Glucan-Branching Enzyme (GBE1) Antibody Market Research Report 2025

Published Date: May 2025

Report Code: QYRE-Auto-7H14348

Global 1 4 Alpha Glucan Branching Enzyme GBE1 Antibody Market Research Report 2023

BUY CHAPTERS

Global 1,4-Alpha-Glucan-Branching Enzyme (GBE1) Antibody Market Research Report 2025

Code: QYRE-Auto-7H14348

Report

May 2025

Pages:88

QYResearch

Buy Now with 15% Discount

DESCRIPTION

TABLE OF CONTENT

TABLES & FIGURES

FEATURED COMPANIES

Sino Biological Inc

Cell Signaling Technology Inc

Bio-Techne

OriGene Technologies, Inc.

Creative-Biolabs

GeneTex

Arigo Biolaboratories Corp

Abcam

RayBiotech

Biomatik

Assay Genie

BioLegend

1,4-Alpha-Glucan-Branching Enzyme (GBE1) Antibody Market

The global market for 1,4-Alpha-Glucan-Branching Enzyme (GBE1) Antibody was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.

North American market for 1,4-Alpha-Glucan-Branching Enzyme (GBE1) Antibody is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

Asia-Pacific market for 1,4-Alpha-Glucan-Branching Enzyme (GBE1) Antibody is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

The global market for 1,4-Alpha-Glucan-Branching Enzyme (GBE1) Antibody in Flow Cytometry is estimated to increase from $ million in 2024 to $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

The major global companies of 1,4-Alpha-Glucan-Branching Enzyme (GBE1) Antibody include Sino Biological, Inc., Cell Signaling Technology, Inc., Bio-Techne, OriGene Technologies, Inc., Creative Biolabs, GeneTex, Arigo Biolaboratories Corp., Abcam, RayBiotech, Inc., Biomatik, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.

This report aims to provide a comprehensive presentation of the global market for 1,4-Alpha-Glucan-Branching Enzyme (GBE1) Antibody, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding 1,4-Alpha-Glucan-Branching Enzyme (GBE1) Antibody.

The 1,4-Alpha-Glucan-Branching Enzyme (GBE1) Antibody market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global 1,4-Alpha-Glucan-Branching Enzyme (GBE1) Antibody market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the 1,4-Alpha-Glucan-Branching Enzyme (GBE1) Antibody companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Market Segmentation

Scope of 1,4-Alpha-Glucan-Branching Enzyme (GBE1) Antibody Market Report

Report Metric	Details
Report Name	1,4-Alpha-Glucan-Branching Enzyme (GBE1) Antibody Market
Segment by Type	Monoclonal Antibody Polyclonal Antibody
Segment by Application	Flow Cytometry ELISA Western Blot Immunoprecipitation Immunofluorescence Other
By Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	Sino Biological, Inc., Cell Signaling Technology, Inc., Bio-Techne, OriGene Technologies, Inc., Creative Biolabs, GeneTex, Arigo Biolaboratories Corp., Abcam, RayBiotech, Inc., Biomatik, Assay Genie, BioLegend
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of 1,4-Alpha-Glucan-Branching Enzyme (GBE1) Antibody company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.

FAQ for this report

Who are the main players in the 1,4-Alpha-Glucan-Branching Enzyme (GBE1) Antibody Market report?

Ans: The main players in the 1,4-Alpha-Glucan-Branching Enzyme (GBE1) Antibody Market are Sino Biological, Inc., Cell Signaling Technology, Inc., Bio-Techne, OriGene Technologies, Inc., Creative Biolabs, GeneTex, Arigo Biolaboratories Corp., Abcam, RayBiotech, Inc., Biomatik, Assay Genie, BioLegend

What are the Application segmentation covered in the 1,4-Alpha-Glucan-Branching Enzyme (GBE1) Antibody Market report?

Ans: The Applications covered in the 1,4-Alpha-Glucan-Branching Enzyme (GBE1) Antibody Market report are Flow Cytometry, ELISA, Western Blot, Immunoprecipitation, Immunofluorescence, Other

What are the Type segmentation covered in the 1,4-Alpha-Glucan-Branching Enzyme (GBE1) Antibody Market report?

Ans: The Types covered in the 1,4-Alpha-Glucan-Branching Enzyme (GBE1) Antibody Market report are Monoclonal Antibody, Polyclonal Antibody

1 Report Overview

1.1 Study Scope

1.2 Market Analysis by Type

1.2.1 Global 1,4-Alpha-Glucan-Branching Enzyme (GBE1) Antibody Market Size Growth Rate by Type: 2020 VS 2024 VS 2031

1.2.2 Monoclonal Antibody

1.2.3 Polyclonal Antibody

1.3 Market by Application

1.3.1 Global 1,4-Alpha-Glucan-Branching Enzyme (GBE1) Antibody Market Growth by Application: 2020 VS 2024 VS 2031

1.3.2 Flow Cytometry

1.3.3 ELISA

1.3.4 Western Blot

1.3.5 Immunoprecipitation

1.3.6 Immunofluorescence

1.3.7 Other

1.4 Assumptions and Limitations

1.5 Study Objectives

1.6 Years Considered

2 Global Growth Trends

2.1 Global 1,4-Alpha-Glucan-Branching Enzyme (GBE1) Antibody Market Perspective (2020-2031)

2.2 Global 1,4-Alpha-Glucan-Branching Enzyme (GBE1) Antibody Growth Trends by Region

2.2.1 Global 1,4-Alpha-Glucan-Branching Enzyme (GBE1) Antibody Market Size by Region: 2020 VS 2024 VS 2031

2.2.2 1,4-Alpha-Glucan-Branching Enzyme (GBE1) Antibody Historic Market Size by Region (2020-2025)

2.2.3 1,4-Alpha-Glucan-Branching Enzyme (GBE1) Antibody Forecasted Market Size by Region (2026-2031)

2.3 1,4-Alpha-Glucan-Branching Enzyme (GBE1) Antibody Market Dynamics

2.3.1 1,4-Alpha-Glucan-Branching Enzyme (GBE1) Antibody Industry Trends

2.3.2 1,4-Alpha-Glucan-Branching Enzyme (GBE1) Antibody Market Drivers

2.3.3 1,4-Alpha-Glucan-Branching Enzyme (GBE1) Antibody Market Challenges

2.3.4 1,4-Alpha-Glucan-Branching Enzyme (GBE1) Antibody Market Restraints

3 Competition Landscape by Key Players

3.1 Global Top 1,4-Alpha-Glucan-Branching Enzyme (GBE1) Antibody Players by Revenue

3.1.1 Global Top 1,4-Alpha-Glucan-Branching Enzyme (GBE1) Antibody Players by Revenue (2020-2025)

3.1.2 Global 1,4-Alpha-Glucan-Branching Enzyme (GBE1) Antibody Revenue Market Share by Players (2020-2025)

3.2 Global 1,4-Alpha-Glucan-Branching Enzyme (GBE1) Antibody Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

3.3 Global Key Players Ranking by 1,4-Alpha-Glucan-Branching Enzyme (GBE1) Antibody Revenue

3.4 Global 1,4-Alpha-Glucan-Branching Enzyme (GBE1) Antibody Market Concentration Ratio

3.4.1 Global 1,4-Alpha-Glucan-Branching Enzyme (GBE1) Antibody Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by 1,4-Alpha-Glucan-Branching Enzyme (GBE1) Antibody Revenue in 2024

3.5 Global Key Players of 1,4-Alpha-Glucan-Branching Enzyme (GBE1) Antibody Head office and Area Served

3.6 Global Key Players of 1,4-Alpha-Glucan-Branching Enzyme (GBE1) Antibody, Product and Application

3.7 Global Key Players of 1,4-Alpha-Glucan-Branching Enzyme (GBE1) Antibody, Date of Enter into This Industry

3.8 Mergers & Acquisitions, Expansion Plans

4 1,4-Alpha-Glucan-Branching Enzyme (GBE1) Antibody Breakdown Data by Type

4.1 Global 1,4-Alpha-Glucan-Branching Enzyme (GBE1) Antibody Historic Market Size by Type (2020-2025)

4.2 Global 1,4-Alpha-Glucan-Branching Enzyme (GBE1) Antibody Forecasted Market Size by Type (2026-2031)

5 1,4-Alpha-Glucan-Branching Enzyme (GBE1) Antibody Breakdown Data by Application

5.1 Global 1,4-Alpha-Glucan-Branching Enzyme (GBE1) Antibody Historic Market Size by Application (2020-2025)

5.2 Global 1,4-Alpha-Glucan-Branching Enzyme (GBE1) Antibody Forecasted Market Size by Application (2026-2031)

6 North America

6.1 North America 1,4-Alpha-Glucan-Branching Enzyme (GBE1) Antibody Market Size (2020-2031)

6.2 North America 1,4-Alpha-Glucan-Branching Enzyme (GBE1) Antibody Market Growth Rate by Country: 2020 VS 2024 VS 2031

6.3 North America 1,4-Alpha-Glucan-Branching Enzyme (GBE1) Antibody Market Size by Country (2020-2025)

6.4 North America 1,4-Alpha-Glucan-Branching Enzyme (GBE1) Antibody Market Size by Country (2026-2031)

6.5 United States

6.6 Canada

7 Europe

7.1 Europe 1,4-Alpha-Glucan-Branching Enzyme (GBE1) Antibody Market Size (2020-2031)

7.2 Europe 1,4-Alpha-Glucan-Branching Enzyme (GBE1) Antibody Market Growth Rate by Country: 2020 VS 2024 VS 2031

7.3 Europe 1,4-Alpha-Glucan-Branching Enzyme (GBE1) Antibody Market Size by Country (2020-2025)

7.4 Europe 1,4-Alpha-Glucan-Branching Enzyme (GBE1) Antibody Market Size by Country (2026-2031)

7.5 Germany

7.6 France

7.7 U.K.

7.8 Italy

7.9 Russia

7.10 Nordic Countries

8 Asia-Pacific

8.1 Asia-Pacific 1,4-Alpha-Glucan-Branching Enzyme (GBE1) Antibody Market Size (2020-2031)

8.2 Asia-Pacific 1,4-Alpha-Glucan-Branching Enzyme (GBE1) Antibody Market Growth Rate by Region: 2020 VS 2024 VS 2031

8.3 Asia-Pacific 1,4-Alpha-Glucan-Branching Enzyme (GBE1) Antibody Market Size by Region (2020-2025)

8.4 Asia-Pacific 1,4-Alpha-Glucan-Branching Enzyme (GBE1) Antibody Market Size by Region (2026-2031)

8.5 China

8.6 Japan

8.7 South Korea

8.8 Southeast Asia

8.9 India

8.10 Australia

9 Latin America

9.1 Latin America 1,4-Alpha-Glucan-Branching Enzyme (GBE1) Antibody Market Size (2020-2031)

9.2 Latin America 1,4-Alpha-Glucan-Branching Enzyme (GBE1) Antibody Market Growth Rate by Country: 2020 VS 2024 VS 2031

9.3 Latin America 1,4-Alpha-Glucan-Branching Enzyme (GBE1) Antibody Market Size by Country (2020-2025)

9.4 Latin America 1,4-Alpha-Glucan-Branching Enzyme (GBE1) Antibody Market Size by Country (2026-2031)

9.5 Mexico

9.6 Brazil

10 Middle East & Africa

10.1 Middle East & Africa 1,4-Alpha-Glucan-Branching Enzyme (GBE1) Antibody Market Size (2020-2031)

10.2 Middle East & Africa 1,4-Alpha-Glucan-Branching Enzyme (GBE1) Antibody Market Growth Rate by Country: 2020 VS 2024 VS 2031

10.3 Middle East & Africa 1,4-Alpha-Glucan-Branching Enzyme (GBE1) Antibody Market Size by Country (2020-2025)

10.4 Middle East & Africa 1,4-Alpha-Glucan-Branching Enzyme (GBE1) Antibody Market Size by Country (2026-2031)

10.5 Turkey

10.6 Saudi Arabia

10.7 UAE

11 Key Players Profiles

11.1 Sino Biological, Inc.

11.1.1 Sino Biological, Inc. Company Details

11.1.2 Sino Biological, Inc. Business Overview

11.1.3 Sino Biological, Inc. 1,4-Alpha-Glucan-Branching Enzyme (GBE1) Antibody Introduction

11.1.4 Sino Biological, Inc. Revenue in 1,4-Alpha-Glucan-Branching Enzyme (GBE1) Antibody Business (2020-2025)

11.1.5 Sino Biological, Inc. Recent Development

11.2 Cell Signaling Technology, Inc.

11.2.1 Cell Signaling Technology, Inc. Company Details

11.2.2 Cell Signaling Technology, Inc. Business Overview

11.2.3 Cell Signaling Technology, Inc. 1,4-Alpha-Glucan-Branching Enzyme (GBE1) Antibody Introduction

11.2.4 Cell Signaling Technology, Inc. Revenue in 1,4-Alpha-Glucan-Branching Enzyme (GBE1) Antibody Business (2020-2025)

11.2.5 Cell Signaling Technology, Inc. Recent Development

11.3 Bio-Techne

11.3.1 Bio-Techne Company Details

11.3.2 Bio-Techne Business Overview

11.3.3 Bio-Techne 1,4-Alpha-Glucan-Branching Enzyme (GBE1) Antibody Introduction

11.3.4 Bio-Techne Revenue in 1,4-Alpha-Glucan-Branching Enzyme (GBE1) Antibody Business (2020-2025)

11.3.5 Bio-Techne Recent Development

11.4 OriGene Technologies, Inc.

11.4.1 OriGene Technologies, Inc. Company Details

11.4.2 OriGene Technologies, Inc. Business Overview

11.4.3 OriGene Technologies, Inc. 1,4-Alpha-Glucan-Branching Enzyme (GBE1) Antibody Introduction

11.4.4 OriGene Technologies, Inc. Revenue in 1,4-Alpha-Glucan-Branching Enzyme (GBE1) Antibody Business (2020-2025)

11.4.5 OriGene Technologies, Inc. Recent Development

11.5 Creative Biolabs

11.5.1 Creative Biolabs Company Details

11.5.2 Creative Biolabs Business Overview

11.5.3 Creative Biolabs 1,4-Alpha-Glucan-Branching Enzyme (GBE1) Antibody Introduction

11.5.4 Creative Biolabs Revenue in 1,4-Alpha-Glucan-Branching Enzyme (GBE1) Antibody Business (2020-2025)

11.5.5 Creative Biolabs Recent Development

11.6 GeneTex

11.6.1 GeneTex Company Details

11.6.2 GeneTex Business Overview

11.6.3 GeneTex 1,4-Alpha-Glucan-Branching Enzyme (GBE1) Antibody Introduction

11.6.4 GeneTex Revenue in 1,4-Alpha-Glucan-Branching Enzyme (GBE1) Antibody Business (2020-2025)

11.6.5 GeneTex Recent Development

11.7 Arigo Biolaboratories Corp.

11.7.1 Arigo Biolaboratories Corp. Company Details

11.7.2 Arigo Biolaboratories Corp. Business Overview

11.7.3 Arigo Biolaboratories Corp. 1,4-Alpha-Glucan-Branching Enzyme (GBE1) Antibody Introduction

11.7.4 Arigo Biolaboratories Corp. Revenue in 1,4-Alpha-Glucan-Branching Enzyme (GBE1) Antibody Business (2020-2025)

11.7.5 Arigo Biolaboratories Corp. Recent Development

11.8 Abcam

11.8.1 Abcam Company Details

11.8.2 Abcam Business Overview

11.8.3 Abcam 1,4-Alpha-Glucan-Branching Enzyme (GBE1) Antibody Introduction

11.8.4 Abcam Revenue in 1,4-Alpha-Glucan-Branching Enzyme (GBE1) Antibody Business (2020-2025)

11.8.5 Abcam Recent Development

11.9 RayBiotech, Inc.

11.9.1 RayBiotech, Inc. Company Details

11.9.2 RayBiotech, Inc. Business Overview

11.9.3 RayBiotech, Inc. 1,4-Alpha-Glucan-Branching Enzyme (GBE1) Antibody Introduction

11.9.4 RayBiotech, Inc. Revenue in 1,4-Alpha-Glucan-Branching Enzyme (GBE1) Antibody Business (2020-2025)

11.9.5 RayBiotech, Inc. Recent Development

11.10 Biomatik

11.10.1 Biomatik Company Details

11.10.2 Biomatik Business Overview

11.10.3 Biomatik 1,4-Alpha-Glucan-Branching Enzyme (GBE1) Antibody Introduction

11.10.4 Biomatik Revenue in 1,4-Alpha-Glucan-Branching Enzyme (GBE1) Antibody Business (2020-2025)

11.10.5 Biomatik Recent Development

11.11 Assay Genie

11.11.1 Assay Genie Company Details

11.11.2 Assay Genie Business Overview

11.11.3 Assay Genie 1,4-Alpha-Glucan-Branching Enzyme (GBE1) Antibody Introduction

11.11.4 Assay Genie Revenue in 1,4-Alpha-Glucan-Branching Enzyme (GBE1) Antibody Business (2020-2025)

11.11.5 Assay Genie Recent Development

11.12 BioLegend

11.12.1 BioLegend Company Details

11.12.2 BioLegend Business Overview

11.12.3 BioLegend 1,4-Alpha-Glucan-Branching Enzyme (GBE1) Antibody Introduction

11.12.4 BioLegend Revenue in 1,4-Alpha-Glucan-Branching Enzyme (GBE1) Antibody Business (2020-2025)

11.12.5 BioLegend Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.1.1 Research Programs/Design

13.1.1.2 Market Size Estimation

13.1.1.3 Market Breakdown and Data Triangulation

13.1.2 Data Source

13.1.2.1 Secondary Sources

13.1.2.2 Primary Sources

13.2 Author Details

13.3 Disclaimer

FEATURED COMPANIES

Sino Biological Inc

Cell Signaling Technology Inc

Bio-Techne

OriGene Technologies, Inc.

Creative-Biolabs

GeneTex

Arigo Biolaboratories Corp

Abcam

RayBiotech

Biomatik

Assay Genie

BioLegend

List of Tables

Table 1. Global 1,4-Alpha-Glucan-Branching Enzyme (GBE1) Antibody Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031

Table 2. Key Players of Monoclonal Antibody

Table 3. Key Players of Polyclonal Antibody

Table 4. Global 1,4-Alpha-Glucan-Branching Enzyme (GBE1) Antibody Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031

Table 5. Global 1,4-Alpha-Glucan-Branching Enzyme (GBE1) Antibody Market Size by Region (US$ Million): 2020 VS 2024 VS 2031

Table 6. Global 1,4-Alpha-Glucan-Branching Enzyme (GBE1) Antibody Market Size by Region (2020-2025) & (US$ Million)

Table 7. Global 1,4-Alpha-Glucan-Branching Enzyme (GBE1) Antibody Market Share by Region (2020-2025)

Table 8. Global 1,4-Alpha-Glucan-Branching Enzyme (GBE1) Antibody Forecasted Market Size by Region (2026-2031) & (US$ Million)

Table 9. Global 1,4-Alpha-Glucan-Branching Enzyme (GBE1) Antibody Market Share by Region (2026-2031)

Table 10. 1,4-Alpha-Glucan-Branching Enzyme (GBE1) Antibody Market Trends

Table 11. 1,4-Alpha-Glucan-Branching Enzyme (GBE1) Antibody Market Drivers

Table 12. 1,4-Alpha-Glucan-Branching Enzyme (GBE1) Antibody Market Challenges

Table 13. 1,4-Alpha-Glucan-Branching Enzyme (GBE1) Antibody Market Restraints

Table 14. Global 1,4-Alpha-Glucan-Branching Enzyme (GBE1) Antibody Revenue by Players (2020-2025) & (US$ Million)

Table 15. Global 1,4-Alpha-Glucan-Branching Enzyme (GBE1) Antibody Market Share by Players (2020-2025)

Table 16. Global Top 1,4-Alpha-Glucan-Branching Enzyme (GBE1) Antibody Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in 1,4-Alpha-Glucan-Branching Enzyme (GBE1) Antibody as of 2024)

Table 17. Ranking of Global Top 1,4-Alpha-Glucan-Branching Enzyme (GBE1) Antibody Companies by Revenue (US$ Million) in 2024

Table 18. Global 5 Largest Players Market Share by 1,4-Alpha-Glucan-Branching Enzyme (GBE1) Antibody Revenue (CR5 and HHI) & (2020-2025)

Table 19. Global Key Players of 1,4-Alpha-Glucan-Branching Enzyme (GBE1) Antibody, Headquarters and Area Served

Table 20. Global Key Players of 1,4-Alpha-Glucan-Branching Enzyme (GBE1) Antibody, Product and Application

Table 21. Global Key Players of 1,4-Alpha-Glucan-Branching Enzyme (GBE1) Antibody, Date of Enter into This Industry

Table 22. Mergers & Acquisitions, Expansion Plans

Table 23. Global 1,4-Alpha-Glucan-Branching Enzyme (GBE1) Antibody Market Size by Type (2020-2025) & (US$ Million)

Table 24. Global 1,4-Alpha-Glucan-Branching Enzyme (GBE1) Antibody Revenue Market Share by Type (2020-2025)

Table 25. Global 1,4-Alpha-Glucan-Branching Enzyme (GBE1) Antibody Forecasted Market Size by Type (2026-2031) & (US$ Million)

Table 26. Global 1,4-Alpha-Glucan-Branching Enzyme (GBE1) Antibody Revenue Market Share by Type (2026-2031)

Table 27. Global 1,4-Alpha-Glucan-Branching Enzyme (GBE1) Antibody Market Size by Application (2020-2025) & (US$ Million)

Table 28. Global 1,4-Alpha-Glucan-Branching Enzyme (GBE1) Antibody Revenue Market Share by Application (2020-2025)

Table 29. Global 1,4-Alpha-Glucan-Branching Enzyme (GBE1) Antibody Forecasted Market Size by Application (2026-2031) & (US$ Million)

Table 30. Global 1,4-Alpha-Glucan-Branching Enzyme (GBE1) Antibody Revenue Market Share by Application (2026-2031)

Table 31. North America 1,4-Alpha-Glucan-Branching Enzyme (GBE1) Antibody Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 32. North America 1,4-Alpha-Glucan-Branching Enzyme (GBE1) Antibody Market Size by Country (2020-2025) & (US$ Million)

Table 33. North America 1,4-Alpha-Glucan-Branching Enzyme (GBE1) Antibody Market Size by Country (2026-2031) & (US$ Million)

Table 34. Europe 1,4-Alpha-Glucan-Branching Enzyme (GBE1) Antibody Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 35. Europe 1,4-Alpha-Glucan-Branching Enzyme (GBE1) Antibody Market Size by Country (2020-2025) & (US$ Million)

Table 36. Europe 1,4-Alpha-Glucan-Branching Enzyme (GBE1) Antibody Market Size by Country (2026-2031) & (US$ Million)

Table 37. Asia-Pacific 1,4-Alpha-Glucan-Branching Enzyme (GBE1) Antibody Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031

Table 38. Asia-Pacific 1,4-Alpha-Glucan-Branching Enzyme (GBE1) Antibody Market Size by Region (2020-2025) & (US$ Million)

Table 39. Asia-Pacific 1,4-Alpha-Glucan-Branching Enzyme (GBE1) Antibody Market Size by Region (2026-2031) & (US$ Million)

Table 40. Latin America 1,4-Alpha-Glucan-Branching Enzyme (GBE1) Antibody Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 41. Latin America 1,4-Alpha-Glucan-Branching Enzyme (GBE1) Antibody Market Size by Country (2020-2025) & (US$ Million)

Table 42. Latin America 1,4-Alpha-Glucan-Branching Enzyme (GBE1) Antibody Market Size by Country (2026-2031) & (US$ Million)

Table 43. Middle East & Africa 1,4-Alpha-Glucan-Branching Enzyme (GBE1) Antibody Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 44. Middle East & Africa 1,4-Alpha-Glucan-Branching Enzyme (GBE1) Antibody Market Size by Country (2020-2025) & (US$ Million)

Table 45. Middle East & Africa 1,4-Alpha-Glucan-Branching Enzyme (GBE1) Antibody Market Size by Country (2026-2031) & (US$ Million)

Table 46. Sino Biological, Inc. Company Details

Table 47. Sino Biological, Inc. Business Overview

Table 48. Sino Biological, Inc. 1,4-Alpha-Glucan-Branching Enzyme (GBE1) Antibody Product

Table 49. Sino Biological, Inc. Revenue in 1,4-Alpha-Glucan-Branching Enzyme (GBE1) Antibody Business (2020-2025) & (US$ Million)

Table 50. Sino Biological, Inc. Recent Development

Table 51. Cell Signaling Technology, Inc. Company Details

Table 52. Cell Signaling Technology, Inc. Business Overview

Table 53. Cell Signaling Technology, Inc. 1,4-Alpha-Glucan-Branching Enzyme (GBE1) Antibody Product

Table 54. Cell Signaling Technology, Inc. Revenue in 1,4-Alpha-Glucan-Branching Enzyme (GBE1) Antibody Business (2020-2025) & (US$ Million)

Table 55. Cell Signaling Technology, Inc. Recent Development

Table 56. Bio-Techne Company Details

Table 57. Bio-Techne Business Overview

Table 58. Bio-Techne 1,4-Alpha-Glucan-Branching Enzyme (GBE1) Antibody Product

Table 59. Bio-Techne Revenue in 1,4-Alpha-Glucan-Branching Enzyme (GBE1) Antibody Business (2020-2025) & (US$ Million)

Table 60. Bio-Techne Recent Development

Table 61. OriGene Technologies, Inc. Company Details

Table 62. OriGene Technologies, Inc. Business Overview

Table 63. OriGene Technologies, Inc. 1,4-Alpha-Glucan-Branching Enzyme (GBE1) Antibody Product

Table 64. OriGene Technologies, Inc. Revenue in 1,4-Alpha-Glucan-Branching Enzyme (GBE1) Antibody Business (2020-2025) & (US$ Million)

Table 65. OriGene Technologies, Inc. Recent Development

Table 66. Creative Biolabs Company Details

Table 67. Creative Biolabs Business Overview

Table 68. Creative Biolabs 1,4-Alpha-Glucan-Branching Enzyme (GBE1) Antibody Product

Table 69. Creative Biolabs Revenue in 1,4-Alpha-Glucan-Branching Enzyme (GBE1) Antibody Business (2020-2025) & (US$ Million)

Table 70. Creative Biolabs Recent Development

Table 71. GeneTex Company Details

Table 72. GeneTex Business Overview

Table 73. GeneTex 1,4-Alpha-Glucan-Branching Enzyme (GBE1) Antibody Product

Table 74. GeneTex Revenue in 1,4-Alpha-Glucan-Branching Enzyme (GBE1) Antibody Business (2020-2025) & (US$ Million)

Table 75. GeneTex Recent Development

Table 76. Arigo Biolaboratories Corp. Company Details

Table 77. Arigo Biolaboratories Corp. Business Overview

Table 78. Arigo Biolaboratories Corp. 1,4-Alpha-Glucan-Branching Enzyme (GBE1) Antibody Product

Table 79. Arigo Biolaboratories Corp. Revenue in 1,4-Alpha-Glucan-Branching Enzyme (GBE1) Antibody Business (2020-2025) & (US$ Million)

Table 80. Arigo Biolaboratories Corp. Recent Development

Table 81. Abcam Company Details

Table 82. Abcam Business Overview

Table 83. Abcam 1,4-Alpha-Glucan-Branching Enzyme (GBE1) Antibody Product

Table 84. Abcam Revenue in 1,4-Alpha-Glucan-Branching Enzyme (GBE1) Antibody Business (2020-2025) & (US$ Million)

Table 85. Abcam Recent Development

Table 86. RayBiotech, Inc. Company Details

Table 87. RayBiotech, Inc. Business Overview

Table 88. RayBiotech, Inc. 1,4-Alpha-Glucan-Branching Enzyme (GBE1) Antibody Product

Table 89. RayBiotech, Inc. Revenue in 1,4-Alpha-Glucan-Branching Enzyme (GBE1) Antibody Business (2020-2025) & (US$ Million)

Table 90. RayBiotech, Inc. Recent Development

Table 91. Biomatik Company Details

Table 92. Biomatik Business Overview

Table 93. Biomatik 1,4-Alpha-Glucan-Branching Enzyme (GBE1) Antibody Product

Table 94. Biomatik Revenue in 1,4-Alpha-Glucan-Branching Enzyme (GBE1) Antibody Business (2020-2025) & (US$ Million)

Table 95. Biomatik Recent Development

Table 96. Assay Genie Company Details

Table 97. Assay Genie Business Overview

Table 98. Assay Genie 1,4-Alpha-Glucan-Branching Enzyme (GBE1) Antibody Product

Table 99. Assay Genie Revenue in 1,4-Alpha-Glucan-Branching Enzyme (GBE1) Antibody Business (2020-2025) & (US$ Million)

Table 100. Assay Genie Recent Development

Table 101. BioLegend Company Details

Table 102. BioLegend Business Overview

Table 103. BioLegend 1,4-Alpha-Glucan-Branching Enzyme (GBE1) Antibody Product

Table 104. BioLegend Revenue in 1,4-Alpha-Glucan-Branching Enzyme (GBE1) Antibody Business (2020-2025) & (US$ Million)

Table 105. BioLegend Recent Development

Table 106. Research Programs/Design for This Report

Table 107. Key Data Information from Secondary Sources

Table 108. Key Data Information from Primary Sources

Table 109. Authors List of This Report

List of Figures

Figure 1. 1,4-Alpha-Glucan-Branching Enzyme (GBE1) Antibody Picture

Figure 2. Global 1,4-Alpha-Glucan-Branching Enzyme (GBE1) Antibody Market Size Comparison by Type (2020-2031) & (US$ Million)

Figure 3. Global 1,4-Alpha-Glucan-Branching Enzyme (GBE1) Antibody Market Share by Type: 2024 VS 2031

Figure 4. Monoclonal Antibody Features

Figure 5. Polyclonal Antibody Features

Figure 6. Global 1,4-Alpha-Glucan-Branching Enzyme (GBE1) Antibody Market Size by Application (2020-2031) & (US$ Million)

Figure 7. Global 1,4-Alpha-Glucan-Branching Enzyme (GBE1) Antibody Market Share by Application: 2024 VS 2031

Figure 8. Flow Cytometry Case Studies

Figure 9. ELISA Case Studies

Figure 10. Western Blot Case Studies

Figure 11. Immunoprecipitation Case Studies

Figure 12. Immunofluorescence Case Studies

Figure 13. Other Case Studies

Figure 14. 1,4-Alpha-Glucan-Branching Enzyme (GBE1) Antibody Report Years Considered

Figure 15. Global 1,4-Alpha-Glucan-Branching Enzyme (GBE1) Antibody Market Size (US$ Million), Year-over-Year: 2020-2031

Figure 16. Global 1,4-Alpha-Glucan-Branching Enzyme (GBE1) Antibody Market Size, (US$ Million), 2020 VS 2024 VS 2031

Figure 17. Global 1,4-Alpha-Glucan-Branching Enzyme (GBE1) Antibody Market Share by Region: 2024 VS 2031

Figure 18. Global 1,4-Alpha-Glucan-Branching Enzyme (GBE1) Antibody Market Share by Players in 2024

Figure 19. Global Top 1,4-Alpha-Glucan-Branching Enzyme (GBE1) Antibody Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in 1,4-Alpha-Glucan-Branching Enzyme (GBE1) Antibody as of 2024)

Figure 20. The Top 10 and 5 Players Market Share by 1,4-Alpha-Glucan-Branching Enzyme (GBE1) Antibody Revenue in 2024

Figure 21. North America 1,4-Alpha-Glucan-Branching Enzyme (GBE1) Antibody Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 22. North America 1,4-Alpha-Glucan-Branching Enzyme (GBE1) Antibody Market Share by Country (2020-2031)

Figure 23. United States 1,4-Alpha-Glucan-Branching Enzyme (GBE1) Antibody Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 24. Canada 1,4-Alpha-Glucan-Branching Enzyme (GBE1) Antibody Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 25. Europe 1,4-Alpha-Glucan-Branching Enzyme (GBE1) Antibody Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 26. Europe 1,4-Alpha-Glucan-Branching Enzyme (GBE1) Antibody Market Share by Country (2020-2031)

Figure 27. Germany 1,4-Alpha-Glucan-Branching Enzyme (GBE1) Antibody Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 28. France 1,4-Alpha-Glucan-Branching Enzyme (GBE1) Antibody Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 29. U.K. 1,4-Alpha-Glucan-Branching Enzyme (GBE1) Antibody Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 30. Italy 1,4-Alpha-Glucan-Branching Enzyme (GBE1) Antibody Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 31. Russia 1,4-Alpha-Glucan-Branching Enzyme (GBE1) Antibody Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 32. Nordic Countries 1,4-Alpha-Glucan-Branching Enzyme (GBE1) Antibody Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 33. Asia-Pacific 1,4-Alpha-Glucan-Branching Enzyme (GBE1) Antibody Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 34. Asia-Pacific 1,4-Alpha-Glucan-Branching Enzyme (GBE1) Antibody Market Share by Region (2020-2031)

Figure 35. China 1,4-Alpha-Glucan-Branching Enzyme (GBE1) Antibody Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 36. Japan 1,4-Alpha-Glucan-Branching Enzyme (GBE1) Antibody Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 37. South Korea 1,4-Alpha-Glucan-Branching Enzyme (GBE1) Antibody Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 38. Southeast Asia 1,4-Alpha-Glucan-Branching Enzyme (GBE1) Antibody Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 39. India 1,4-Alpha-Glucan-Branching Enzyme (GBE1) Antibody Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 40. Australia 1,4-Alpha-Glucan-Branching Enzyme (GBE1) Antibody Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 41. Latin America 1,4-Alpha-Glucan-Branching Enzyme (GBE1) Antibody Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 42. Latin America 1,4-Alpha-Glucan-Branching Enzyme (GBE1) Antibody Market Share by Country (2020-2031)

Figure 43. Mexico 1,4-Alpha-Glucan-Branching Enzyme (GBE1) Antibody Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 44. Brazil 1,4-Alpha-Glucan-Branching Enzyme (GBE1) Antibody Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 45. Middle East & Africa 1,4-Alpha-Glucan-Branching Enzyme (GBE1) Antibody Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 46. Middle East & Africa 1,4-Alpha-Glucan-Branching Enzyme (GBE1) Antibody Market Share by Country (2020-2031)

Figure 47. Turkey 1,4-Alpha-Glucan-Branching Enzyme (GBE1) Antibody Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 48. Saudi Arabia 1,4-Alpha-Glucan-Branching Enzyme (GBE1) Antibody Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 49. UAE 1,4-Alpha-Glucan-Branching Enzyme (GBE1) Antibody Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 50. Sino Biological, Inc. Revenue Growth Rate in 1,4-Alpha-Glucan-Branching Enzyme (GBE1) Antibody Business (2020-2025)

Figure 51. Cell Signaling Technology, Inc. Revenue Growth Rate in 1,4-Alpha-Glucan-Branching Enzyme (GBE1) Antibody Business (2020-2025)

Figure 52. Bio-Techne Revenue Growth Rate in 1,4-Alpha-Glucan-Branching Enzyme (GBE1) Antibody Business (2020-2025)

Figure 53. OriGene Technologies, Inc. Revenue Growth Rate in 1,4-Alpha-Glucan-Branching Enzyme (GBE1) Antibody Business (2020-2025)

Figure 54. Creative Biolabs Revenue Growth Rate in 1,4-Alpha-Glucan-Branching Enzyme (GBE1) Antibody Business (2020-2025)

Figure 55. GeneTex Revenue Growth Rate in 1,4-Alpha-Glucan-Branching Enzyme (GBE1) Antibody Business (2020-2025)

Figure 56. Arigo Biolaboratories Corp. Revenue Growth Rate in 1,4-Alpha-Glucan-Branching Enzyme (GBE1) Antibody Business (2020-2025)

Figure 57. Abcam Revenue Growth Rate in 1,4-Alpha-Glucan-Branching Enzyme (GBE1) Antibody Business (2020-2025)

Figure 58. RayBiotech, Inc. Revenue Growth Rate in 1,4-Alpha-Glucan-Branching Enzyme (GBE1) Antibody Business (2020-2025)

Figure 59. Biomatik Revenue Growth Rate in 1,4-Alpha-Glucan-Branching Enzyme (GBE1) Antibody Business (2020-2025)

Figure 60. Assay Genie Revenue Growth Rate in 1,4-Alpha-Glucan-Branching Enzyme (GBE1) Antibody Business (2020-2025)

Figure 61. BioLegend Revenue Growth Rate in 1,4-Alpha-Glucan-Branching Enzyme (GBE1) Antibody Business (2020-2025)

Figure 62. Bottom-up and Top-down Approaches for This Report

Figure 63. Data Triangulation

Figure 64. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$2900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Enzyme Immunoassay Analyzer Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global J Chain Antibody Market Research Report 2024

Global GFAP Antibody Market Research Report 2024

Global JAG1 Antibody Market Research Report 2024

Global Erk1 Antibody Market Research Report 2024

Global EXT1 Antibody Market Research Report 2025

Global β Agarase Market Research Report 2025

Global Glucobay Market Research Report 2024

Global PECAM 1 Antibody Market Research Report 2024

Global ALK 1 Antibody Market Research Report 2024

Hemagglutinin Antibody Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global GNS Glucosamine GNS Antibody Market Research Report 2025

Hemojuvelin Antibody Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global PARP1 Antibody Market Research Report 2024

Global In vitro Glyco Engineering IVGE Market Research Report 2025

Global β Glucuronidase Enzymes Market Research Report 2025

Fully Automatic Glycated Hemoglobin Analysis System Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Antibodies Market Research Report 2024

Global G Protein Coupled Bile Acid Receptor 1 Market Research Report 2024

RELATED REPORTS

Global Pharma and Healthcare Social Media Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-14Y6812

Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Global Food Additives Testing Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-34O3983

Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Global Gabapentin API Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-9V17601

Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Global Electronic Informed Consent Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-22C17047

Fri Sep 12 00:00:00 UTC 2025

Add to Cart

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions